The University of Chicago Header Logo

Connection

Ryan Widau to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications Ryan Widau has written about Clinical Trials, Phase III as Topic.
Ryan Widau
Connection Strength
0.094
Clinical Trials, Phase III as Topic
  1. Prognostic and Predictive Factors in Patients with Advanced HCC and Elevated Alpha-Fetoprotein Treated with Ramucirumab in Two Randomized Phase III Trials. Clin Cancer Res. 2022 06 01; 28(11):2297-2305.
    View in: PubMed
    Score: 0.048
  2. Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiology. Liver Int. 2021 11; 41(11):2759-2767.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.